MAI Capital Management Has $8.90 Million Stock Holdings in iShares Biotechnology ETF $IBB

MAI Capital Management trimmed its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 28.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 70,346 shares of the financial services provider’s stock after selling 27,812 shares during the quarter. MAI Capital Management owned 0.17% of iShares Biotechnology ETF worth $8,899,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Ramirez Asset Management Inc. bought a new position in shares of iShares Biotechnology ETF during the 1st quarter worth approximately $26,000. Berkshire Money Management Inc. bought a new position in iShares Biotechnology ETF during the 2nd quarter valued at about $28,000. Financial Gravity Companies Inc. acquired a new position in iShares Biotechnology ETF in the second quarter valued at about $29,000. Harbor Asset Planning Inc. bought a new stake in shares of iShares Biotechnology ETF during the second quarter worth approximately $31,000. Finally, Trust Co. of Toledo NA OH bought a new position in iShares Biotechnology ETF in the second quarter valued at approximately $32,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Up 2.0%

Shares of iShares Biotechnology ETF stock opened at $167.52 on Friday. iShares Biotechnology ETF has a 52 week low of $107.43 and a 52 week high of $168.73. The firm has a fifty day moving average of $153.36 and a two-hundred day moving average of $138.34.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were issued a dividend of $0.0828 per share. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 annualized dividend and a yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.